ArticlemHealth2025
Mobile App Rating Scale (User Version) for the assessment of a community health worker medical application.
Article in mHealth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development, content validation and quality evaluation of a mobile app for oral health surveillance: a modified Delphi approach.Journal of oral biology and craniofacial researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Noncommunicable diseases (NCDs) pose a significant burden in the Philippines, with cardiovascular and cerebrovascular diseases among the leading causes of mortality. The Department of Health implemented the Philippine Package of Essential Non-Communicable Disease Interventions (Phil PEN) to address this issue. However, healthcare professionals faced challenges in implementing the program due to the cumbersome nature of the multiple forms required for patient risk assessment. To address this, a mobile medical app, the PhilPEN Risk Stratification application (App), was developed for community health workers (CHWs) using the extreme prototyping framework. This study aimed to assess the usability of the PhilPEN Risk Stratification App using the (User Version) Mobile App Rating Scale (uMARS)'s 1-5 rating system and to determine the utility of uMARS in app development. The secondary objective was to evaluate whether the app could achieve an acceptable uMARS rating score (>3), highlighting the significance of quality monitoring through validated metrics in improving the adoption and continuous iterative development of medical mobile apps. Methods: The study employed both quantitative and qualitative research methodologies, including key informant interviews, linguistic validation, and cognitive debriefing. The extreme prototyping framework was used for app development, involving iterative refinement through progressively functional prototypes. CHWs from a designated health center participated in the app development and evaluation process, providing feedback and using the app to collect data from patients. Results: The uMARS scores for the PhilPEN Risk Stratification App were above the targeted acceptable rating, with an objective quality rating of 4.05 and a personal opinion/subjective quality rating of 3.25. The app scored well in functionality (4.19), aesthetics (4.08), and information (4.41), indicating its accuracy, ease of use, and provision of high-quality information. The engagement score (3.53) was lower due to the app's primary focus on healthcare rather than entertainment. Conclusions: The study demonstrated the effectiveness of the extreme prototyping framework in developing a medical mobile app and the utility of uMARS as a guide for authoring high-quality mobile health apps. The uMARS metrics were beneficial in setting developer expectations, identifying strengths and weaknesses, and guiding the iterative improvement of the app. Further assessment with more CHWs and patients is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.